Latest Artificial Intelligence News

IMEXHS Limited has secured a significant one-year contract with Colombian cancer care provider Oncolife to deliver advanced radiology services, leveraging its integrated software and AI tools to enhance diagnostic precision.

CDC, Infratil’s data centre arm, has locked in approximately 100MW of new contracted capacity, reinforcing strong demand driven by cloud and AI workloads in Australasia. This milestone supports CDC’s target to double FY25 earnings by FY27.

Raiz Invest Limited reported robust FY25 results with record active customers and funds under management, underpinned by strategic partnerships and AI-driven innovation. The company projects positive earnings growth for FY26 amid a competitive fintech landscape.

Way2VAT is advancing its position as a global leader in digital tax processing through a strategic acquisition and a robust four-pillar growth plan, targeting profitability by 2026 amid expanding market opportunities.

Alcidion Group has expanded its contract with North Cumbria Integrated Care NHS Foundation Trust to integrate MediViewer into its Miya Precision electronic patient record system, enhancing access to scanned and historical documents.

SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.

Decidr AI Industries has successfully completed a $20 million placement, positioning itself to accelerate international growth and advance its AI technology platform.

HeraMED is fast-tracking its AI-driven maternity care technologies, including an early release of its AI Clinician Assistant and predictive models for high-risk pregnancies, aiming to revolutionize digital women’s health globally.

NoviqTech has launched beta versions of its pioneering quantum AI products, QI Provenance and QI AI, marking a significant step toward commercialising hybrid quantum-classical computing solutions. The company also announced plans for a powerful CUDA-Q enhanced platform promising up to tenfold acceleration in complex computing tasks.

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.